Diabetes

Organisation: forskargrupp

Forskningsområden

Ämnesklassifikation (UKÄ)

  • Endokrinologi och diabetes

Forskning

This project aims to develop incretin therapy as a glucose-reducing strategy in type 2 diabetes (T2D). Its particular focus is to understand the mechanisms of incretin therapy and to optimize its clinical positioning. This mission is achieved by an interdisciplinary approach with complementary studies in subjects with T2D, healthy volunteers and experimental animals.

Senaste forskningsoutput

Bo Ahrén, 2019 jun 19, I : Frontiers in Endocrinology. 10, JUN, 376.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Ahmadi, S., Karin Filipsson, Dimenäs, H., Isaksson, S., Imberg, H., Sjöberg, S., Bo Ahrén, Dahlqvist, S., Gustafsson, T., Tuomilehto, J., Hirsch, I. & Lind, M., 2019, I : Obesity Science Practice. 5, 2, s. 130-140

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Visa alla (39)